Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

1700P - Functional status in older patients with lung and thoracic cancer

Date

16 Sep 2021

Session

ePoster Display

Topics

Cancer in Older Adults

Tumour Site

Thoracic Malignancies

Presenters

Anne-Laure Couderc

Citation

Annals of Oncology (2021) 32 (suppl_5): S1175-S1198. 10.1016/annonc/annonc714

Authors

A. Couderc1, P. Tomasini2, L. Greillier2, E. Nouguerede1, D. Rey3, C. Montegut2, P. Thomas4, F. Barlesi5, P. Villani1

Author affiliations

  • 1 Médecine Interne Et Gériatrie Thérapeutique, Assistance Publique Hopitaux de Marseille, 13009 - Marseille/FR
  • 2 Multidisciplinary Oncology And Therapeutic Innovations, Hopital St. Marguerite Assistance Publique Hopitaux de Marseille, 13015 - Marseille/FR
  • 3 Sestim, SESTIM-INSERM UMR912- IRD - AMU, Marseille/FR
  • 4 Thoracic Oncology, pascal-alexandre.thomas@mail.ap-hm.fr, 13000 - Marseille/FR
  • 5 Medical Oncology, Gustave Roussy - Cancer Campus, 94805 - Villejuif/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1700P

Background

Functional status (FS) including Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) is part of the Comprehensive Geriatric Assessment (CGA).

Methods

This study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients aged 70 years or older referred for a CGA before initiation of lung and thoracic cancer treatment were enrolled. Our objective was to assess the impact of combination of the information collected with the ADL and short IADL scales on overall survival (OS) and unplanned hospitalizations within three months in older patients treated for lung and thoracic cancers.

Results

227 patients were recruited. The median age was 78.7 years and 74.0 % were male. The majority of the patients were diagnosed with non-small cell lung cancer (82%). Concerning FS, 41.9% of patients had unimpaired ADL-IADL, 26.0% had impaired IADL alone, 4.0% had impaired ADL alone, and 28.1% had impaired ADL-IADL. ADL-IADL impairment was associated with poor nutritional status, mobility, or cognitive disorders (p<0.001). In a logistic regression model, ADL or IADL impairment (OR=2.1; 95% CI [1.0-4.2]) and impaired ADL-IADL (OR=2.6; 95% CI [1.2-5.3]) were independently associated with a higher risk of unplanned hospitalizations within 3 months. In the multivariate Cox model, a decrease in OS was independently associated with impaired ADL-IADL (aHR=2.4; 95% CI [1.5-3.9]).

Conclusions

Combining the ADL and IADL scales to evaluate FS of older patients with lung or thoracic cancer could be a new efficient tool in CGA.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.